Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Intermittent Claudication Clinical Trials

A listing of Intermittent Claudication medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (2) clinical trials

Evaluation of FM220 in Patients With Peripheral Arterial Disease (PAD)

The purpose of this study is to determine whether 12 weeks of daily home use of the FM220 in the most affected leg of patients with PAD and claudication, will improve peak walking time (PWT) at three months as compared with a non-treated control group.


Randomized Phase IIb Trial of DVC1-0101

DVC1-0101 is a gene therapy medicine to treat peripheral arterial disease (PAD) based on recombinant F-gene-deleted, non-transmissible Sendai virus (rSeV/dF) expressing human fibroblast growth factor-2 (FGF-2) gene. The previous Phase I/IIa study demonstrated no serious adverse event related to the administration, and suggested possible improvement of local blood flow and ...